Warfarin and its interactions with foods, herbs and other dietary supplements (Q34566453)

3 August 2017

1 reference

title

Warfarin and its interactions with foods, herbs and other dietary supplements (English)

1 reference

3 August 2017

1 reference

Edith A Nutescu

1

1 reference

3 August 2017

Nancy L Shapiro

series ordinal

2

1 reference

3 August 2017

Sonia Ibrahim

series ordinal

3

1 reference

3 August 2017

Patricia West

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Expert Opinion on Drug Safety

3 August 2017

published in

1 reference

3 August 2017

volume

5

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

433-451

1 reference

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Systematic overview of warfarin and its drug and food interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Complimentary and alternative medicine use among patients starting warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Trends in use of herbal and nutritional supplements in cardiovascular patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Americans' views on the use and regulation of dietary supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Vitamin K and oral anticoagulation: thought for food

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Warfarin antagonism by avocado

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Possible warfarin failure due to interaction with smokeless tobacco

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Pharmacokinetic interactions between alcohol and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Grapefruit juice-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Possible interaction between warfarin and cranberry juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Increased salicylate concentrations in urine of human volunteers after consumption of cranberry juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Possible interaction between warfarin and Lycium barbarum L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Herbal drug curbicin and anticoagulant effect with and without warfarin: possibly related to the vitamin E component

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effect of vitamin E on the anticoagulant response to warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

The effect of garlic supplements on the pharmacokinetics of saquinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Interaction between warfarin and mango fruit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Inhibition of warfarin anticoagulation associated with chelation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Herbal medicines and perioperative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Herbal interactions with cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Physico-chemical interactions between extracts of Hypericum perforatum L. and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Probable antagonism of warfarin by green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Glucosamine sulfate does not crossreact with the antibodies of patients with heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Traditional remedies and food supplements. A 5-year toxicological study (1991-1995).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effect of soy milk on warfarin efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Interaction between warfarin and danshen (Salvia miltiorrhiza)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Potentiation of warfarin by dong quai

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Patients, power and politics: from patients to citizens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Potential interaction between warfarin and boldo-fenugreek

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Herbal composition PC-SPES for management of prostate cancer: identification of active principles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Drug interactions between herbal and prescription medicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

A systematic review and inventory of supplement effects on warfarin and other anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Herb-drug interactions: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Fish oil interaction with warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Chinese herbs and warfarin potentiation by 'Danshen'

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

A pharmacologic overview of current and emerging anticoagulants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effect of dietary fat content on oral bioavailability of menatetrenone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effect of the moderate consumption of olestra in patients receiving long-term warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

The effect of avocado oils on some liver characteristics in growing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Garlic and the risk of TURP bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Subarachnoid haemorrhage associated with Ginkgo biloba

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Spontaneous hyphema associated with ingestion of Ginkgo biloba extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Association of Ginkgo biloba with intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Ginkgo biloba extract markedly induces pentoxyresorufin O-dealkylase activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Effect of non-saponin fraction from Panax ginseng on cGMP and thromboxane A2 in human platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Tea and coffee brews are not dietary sources of vitamin K-1 (phylloquinone)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Reduced effect of warfarin caused by ubidecarenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

A taste of Chinese medicine!

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Warfarin interactions with Chinese traditional medicines: danshen and methyl salicylate medicated oil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

Danggui (Angelica sinensis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.3.433

21 January 2018

Identifiers

DOI

10.1517/14740338.5.3.433

1 reference

3 August 2017

1 reference